Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proceedings of the 15<sup>th</sup> International Newborn Brain Conference: Neonatal Neurocritical Care, seizures, and continuous aEEG and /or EEG monitoring: Fota Island, Cork, Ireland, February 28<sup>th</sup> - March 2<sup>nd</sup> 2024.

Journal of neonatal-perinatal medicine·2025
Same author

Association of Two Neonatal Encephalopathy Scores with Neurophysiology in Newborns with Suspected Hypoxic-Ischemic Encephalopathy.

Neonatology·2025
Same author

Establishing a regional registry for neonatal encephalopathy: impact on identification of gaps in practice.

Pediatric research·2023
Same author

Expert Consensus on Currently Accepted Measures of Harm.

Journal of patient safety·2020
Same author

Patient Engagement Activities and Patient Experience: Are Patients With a History of Depression the Canary in the Coal Mine?

Medical care research and review : MCRR·2019
Same author

Role of Patient Safety Organizations in Improving Patient Safety.

Obstetrics and gynecology clinics of North America·2019

Related Experiment Video

Updated: May 27, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Guided medication dosing for elderly emergency patients using real-time, computerized decision support.

Richard T Griffey1, Helen G Lo, Elisabeth Burdick

  • 1Division of Emergency Medicine, Washington University Institute for Public Health, St. Louis, Missouri, USA. griffeyr@wustl.edu

Journal of the American Medical Informatics Association : JAMIA
|November 5, 2011
PubMed
Summary
This summary is machine-generated.

Computerized decision support for elderly medication dosing in the emergency department increased physician adherence to recommendations and reduced adverse drug events (ADEs). This technology shows promise for improving patient safety in geriatric care.

Related Experiment Videos

Last Updated: May 27, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

  • Health Informatics
  • Geriatric Medicine
  • Emergency Medicine

Background:

  • Elderly patients are at higher risk for adverse drug events (ADEs) due to physiological changes and polypharmacy.
  • Medication dosing in the emergency department (ED) requires careful consideration for geriatric patients.
  • Computerized decision support systems (CDSS) offer potential to optimize medication management.

Purpose of the Study:

  • To assess the impact of a real-time CDSS on physician prescribing behavior for elderly patients in the ED.
  • To evaluate the effect of the CDSS on the incidence of adverse drug events (ADEs) in this population.

Main Methods:

  • A prospective controlled trial utilized an alternating OFF/ON design of a CDSS over 26 weeks.
  • The study focused on patients aged 65 and older receiving specific medications (benzodiazepines, opiates, NSAIDs, sedative-hypnotics).
  • Physician adherence to CDSS recommendations (dosing adjustments or alternative medications) and ADE rates were primary outcomes.

Main Results:

  • Physician orders were more consistent with CDSS dosing recommendations when the system was ON (31.4%) compared to OFF (23%) (p≤0.0001).
  • Despite low acceptance of alternative medication suggestions (92.5% declined), overall adherence to dosing guidance improved.
  • The rate of adverse drug events (ADEs) was significantly lower when the CDSS was active (3.4%) versus inactive (7.1%) (p=0.02).

Conclusions:

  • Real-time computerized decision support, even with limited acceptance of medication changes, led to increased adherence to dosing recommendations.
  • The implementation of this CDSS was associated with a reduction in adverse drug events in elderly ED patients.
  • Further research is warranted, acknowledging the single-institution, retrospective ADE review limitations.